Press Releases

Renowned Surgeon Presents Evidence of Abortion/Breast Cancer Link

Hoffman Estates, Illinois - Angela Lanfranchi, MD, FACS, Clinical Assistant, and Professor of Surgery at the Robert Wood Johnson Medical Center in Piscataway, New Jersey, will present two public seminars on breast cancer entitled "The Impact of Reproductive Choices and the Risk of Breast Cancer" :

Thursday, November 2, 2006       11:30 a.m. until 1:30 p.m.
James R. Thompson Center, 100 W. Randolph St, Rm 503, 16th Fl, Chicago;

Friday, November 3, 2006         12:30 p.m. to 1:30 p.m.
University of Illinois Medical School, 1853 W. Polk St., Rm 221 CMW, Chicago

Scientific Review Recommends Informing Patients about Abortion-Breast Cancer Link, Risks of Birth Control Pills and Menopausal Therapy

The real war on women!

School Board's Decision in Willamina, Oregon Will Put Students at Risk for Three Cancers

In 2005, World Health Organization (WHO) scientists assigned estrogen plus progestin (combined) hormonal contraceptives (the pill) and combined hormone replacement therapy (HRT) the highest level of carcinogenicity - Group 1. 1

Coalition on Abortion/Breast Cancer Chastises the U.K.'s Royal College of Obstetricians and Gynecologists for Deceiving Women About Abortion-Breast Cancer Link

The Coalition on Abortion/Breast Cancer chastised the U.K.'s abortionists at the Royal College of Obstetricians and Gynecologists (RCOG) today for publishing a statement in its revised guidelines entitled, "The care of women seeking induced abortion," which falsely claims "induced abortion is not associated with an increase in breast cancer risk." 1

"The RCOG's statement is shameful, unethical, and totally self-serving. It has more to do with protecting abortionists from massive medical malpractice lawsuits and absolutely nothing to do with scientific evidence," said Karen Malec, president of the Coalition. "The RCOG's abortionists are following the tobacco industry's playbook."

Congressional Candidate Doug LaMalfa Was Right the First Time: Abortion Raises Breast Cancer Risk

Doug LaMalfa, a candidate for California’s first Congressional district, was right when he said on Monday, September 10, 2012 that women who have abortions are more likely to get cancer. 1 Unfortunately, LaMalfa retracted his statement on Tuesday, saying current research doesn’t support it. He cited the U.S. National Cancer Institute (NCI) and the American Cancer Society.

LEGISLATIVE MEASURES AT FEDERAL, STATE LEVELS WILL WORSEN BREAST CANCER, PREMATURE BIRTH EPIDEMICS

President Obama, U.S. Rep. Jerrold Nadler and legislators in Texas, Illinois and New York support legislation that will have the unintentional effect of deepening the breast cancer and premature birth epidemics. To educate policy makers, the Coalition on Abortion/Breast Cancer is publishing the Breast Cancer Prevention Institute's document summarizing the state of the research on the abortion-breast cancer link and discussing the risk of premature birth.  It is available at:    

Planned Parenthood’s Cancer War on Women Continues 40 Years After U.S. Supreme Court Made Induced Abortion Legally Accessible Throughout Pregnancy

Planned Parenthood reported in its 2008 tax returns that its purpose is "[a]chieving, through informed individual choice, a U.S. population of stable size in an optimum environment; in stimulating and sponsoring relevant biomedical, socio-economic, and demographic research." 1

The Coalition on Abortion/Breast Cancer reported that British researcher Patrick Carroll presented his research on abortion as the "best predictor of British breast cancer trends" at a conference in Paris sponsored by the National Institute for Demographic Studies on September 7, 2005. Carroll is director of the London-based Pensions and Population Research Institute.  The conference was attended by statisticians and epidemiologists.

Carroll provided forecasts of the increased incidence of breast cancers to be expected in Great Britain in the next 25 years.   He reported three trends:

1. British upper class women are more likely to develop breast cancer and to die of the disease than are lower class women. Upper class women are more likely to delay the birth of a first child and to abort before the birth of a first child. These are highly carcinogenic abortions.

President Obama, Nancy Pelosi, Harry Reid Show Anti-Woman Bias with Abortion Mandate / Ignore National Cancer Institute Branch Chief's Admission of Abortion-Breast Cancer Link

A spokesperson for the Coalition on Abortion/Breast Cancer said today that President Obama, Speaker Nancy Pelosi and Senator Harry Reid are damaging the health of women and their future children with a healthcare bill that promises to increase the rates of abortion, breast cancer and premature birth. The Coalition's president, Karen Malec, said: 

WOMEN'S GROUP DENOUNCES MINNESOTA GOVERNOR'S DECISION TO MINIMIZE ABORTION-BREAST CANCER FINDINGS

The Coalition on Abortion/Breast Cancer condemns Minnesota Governor Tim Pawlenty's decision to revise wording about the abortion-breast cancer (ABC) link in a handbook provided by the state's Health Department.  The coalition deplores efforts by Planned Parenthood and the Minnesota Medical Association (MMA) to pressure Pawlenty to conceal the overwhelming evidence supporting abortion as a risk factor for breast cancer.

"These groups are following the tobacco industry's playbook," said Karen Malec, president of the coalition.  "Human life is of no importance to them.   They care only for one thing - abortion industry profits.  They're petrified because the nation's first ABC malpractice lawsuit was settled late last year."

"[A]fter the Hiroshima atomic bomb exposed women to high doses of radiation, it was young, nulliparous (childless) women who later developed breast cancer while the older parous (with children) women did not." Angela Lanfranchi, MD, Clinical Assistant Professor of Surgery, Robert Wood Johnson Medical School; and President, Breast Cancer Prevention Institute.

Study: Pregnancy Outcomes Influence Breast Cancer Risk

A paper published this week in the journal, The Linacre Quarterly, by Angela Lanfranchi, MD shows how different pregnancy outcomes influence breast cancer risk. She explains, in simple terms, the biological reasons for each risk. 1  Citing 52 years of research, she said the evidence shows that:

Women's Group Warns about Von Eschenbach's Appointment as Acting FDA Commissioner

"Ladies, take cover! Andrew Von Eschenbach was named acting commissioner of the U.S. Food and Drug Administration (FDA) on Friday," warned Karen Malec, president of the Coalition on Abortion/Breast Cancer. "The FDA had a commissioner who could resist political pressure. His abrupt resignation after two months on the job creates the impression that the Bush Administration couldn't take the heat from the abortion and the pharmaceutical industries. The industries want Plan B (morning-after pill) made available for over-the-counter sales."

"Von Eschenbach is no friend of women," warned Malec, a cancer survivor.  "He's a friend of the anti-woman abortion and pharmaceutical industries."

WOMEN'S GROUP APPLAUDS BRITISH MP's ABORTION-CANCER PROBE / CRITICIZES DR. STUART DONNAN's HYPOCRISY

The Coalition on Abortion/Breast Cancer welcomes the efforts of British MP Claire Curtis-Thomas and her colleagues who asked doctors to examine women's reproductive histories and the abortion-breast cancer (ABC) link within their patient populations.  The coalition condemns the efforts of Manchester University Professor Stuart Donnan to disabuse women of the truth that abortion raises breast cancer risk.  Donnan misled the BBC by saying "some studies" reported risk elevations, but others show abortion reduces risk. 1

Coalition on Abortion/Breast Cancer
Press Release
Date: December 2, 2008

MEDICAL MALPRACTICE EXPLAINS HIGH PREMATURE BIRTH RATE AMONG BLACK AMERICANS, REPORT RESEARCHERS: "ONLY FULL TERM PREGNANCIES REDUCE MOTHERS' BREAST CANCER RISK"

A new article in the Journal of American Physicians and Surgeons says African American women are being disproportionately exposed to an unsafe surgical procedure that is a "probable cause" of the high preterm birth rate among blacks. 1

The authors, Brent Rooney and his colleagues, cited numerous studies, the Institute of Medicine, and other authorities acknowledging the abortion-preterm birth (APB) link.  

ABORTION-BREAST CANCER LINK, HORMONES DISCUSSED AT NATIONAL LAWYERS ASSOCIATION CONFERENCE

Attorneys attending a conference sponsored by the National Lawyers Association at Chicago's Kent College of Law on August 1 heard speakers discuss the abortion-breast cancer (ABC) link and the role of hormones in the development of breast cancer.

Mayer Eisenstein, MD, JD, MPH, said that estrogen is connected with the development of most breast cancers.  Eisenstein's speech is relevant to the ABC link because women are exposed to more estrogen during normal pregnancies (but not most miscarriages) than at any other time during their lives.  This effect is only corrected in the third trimester when breast cells are matured into cancer-resistant tissue.

The government's Report on Carcinogens included steroidal estrogens (used in oral contraceptives and estrogen replacement therapy) on its list of "known carcinogens" last year.

Eisenstein said, "Anyone who's on (them) unavoidably increases breast cancer risk."  Having more children, starting at an earlier age, reduces lifetime risk.

Johnson & Johnson's Sales of Cancer-Causing Birth Control Pills Comparable to Tobacco Industry's Corporate Greed, Says Coalition on Abortion/Breast Cancer

"Real hatred of women involves their exploitation through sales of cancer-causing hormonal contraceptive steroids," Karen Malec, president of the Coalition on Abortion/Breast Cancer.

The Coalition on Abortion/Breast Cancer condemns Johnson & Johnson's and its shareholders' decision to continue selling cancer-causing birth control pills to young women instead of protecting their lives and striving to reduce breast cancer rates.

On April 28, 2011, Dr. Chris Kahlenborn, a medical adviser for the Coalition, presented a resolution at a shareholder's meeting on behalf of a shareholder, Human Life International. The resolution proposed a change in J&J's policy - that it would not discriminate in employment against breast cancer survivors, including those voicing opposition to the sale of the pill. Shareholders rejected the proposal after J&J's board sent a message saying they "did not believe the resolution is necessary."

Press Misses Huge Story about National Academies of Science Recognition of Abortion-Premature Birth Link, Says Coalition on Abortion/Breast Cancer